# US 2020/0002777 A1 · Antimicrobial strain

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 2020/0002777 A1
- Document ID: US20200002777A1
- Status: Published application
- Kind: A1
- Application number: 16/463,348
- Filed: 2017-11-24
- Published: 2020-01-02
- Earliest claimed: 2016-11-24
- Assignees: Servizo Galego De Saude (Sergas); Universidade De Santiago De Compostela (Usc)
- Applicants: Servizo Galego De Saude (Sergas); UNIVERSIDADE DE SANTIAGO DE COMPOSTELA (usc)
- Inventors: Lucía MARTÍNEZ LAMAS; Maximiliano ÁLVAREZ FERNÁNDEZ; Pedro DIZ DIOS; Jacobo LIMERES POSSE
- Web page: https://patentgrep.com/patent/US20200002777A1

## CPC

- A61K 35/744: Lactic acid bacteria, e.g. enterococci, pediococci, lactococci, streptococci or leuconostocs
- C12N 1/205: Bacterial isolates
- A23L 29/212: Starch; Modified starch; Starch derivatives, e.g. esters or ethers (containing starch hydrolysates, e.g. dextrin, A23L29/30)
- A23L 29/35: {Degradation products of starch, e.g. hydrolysates, dextrins; Enzymatically modified starches}
- A23L 33/125: containing carbohydrate syrups; containing sugars; containing sugar alcohols; containing starch hydrolysates (indigestible substances A23L33/21)
- A23L 33/135: Bacteria or derivatives thereof, e.g. probiotics
- A61K 9/0053: {Mouth and digestive tract, i.e. intraoral and peroral administration}
- C12R 2001/46: Streptococcus {; Enterococcus; Lactococcus}
- A61K: PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES (devices or methods specially adapted for bringing pharmaceutical products into particular physical or administering forms A61J3/00; chemical aspects of, or use of materials for deodorisation of air, for disinfection or sterilisation, or for bandages, dressings, absorbent pads or surgical articles A61L; soap compositions C11D)
- C12N: MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA (microbiological testing media C12Q1/00)
- A23L: FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF (preservation thereof A23B)
- C12R: INDEXING SCHEME ASSOCIATED WITH SUBCLASSES C12C - C12Q, RELATING TO MICROORGANISMS

## Abstract

The present invention belongs to the field of the biotechnology, and relates to novel Streptococcusbacteria which are useful as antimicrobial agents, particularly against caries and periodontal disease. The invention relates to compositions and functional food comprising the novel bacteria. In particular, the present invention relates to a novel bacterial strain, deposited at the Colección Española de Cultivos Tipo, with accession number CECT 9174, which has proven to be useful in the prevention and treatment of caries and periodontal disease.

## Claims

### Claim 1

A bacterial strain deposited at the Colección Española de Cultivos Tipo (CECT) by Servicio Galego de Saúde (SERGAS), on Jul. 20, 2016, with accession number CECT 9174.

### Claim 2 (depends on 1)

The bacterial strain of claim 1, for use as a medicament.

### Claim 3 (depends on 1)

The bacterial strain of claim 1, for use as an anti-microbial medicament.

### Claim 4 (depends on 1)

The bacterial strain of claim 1, for use in the prevention or therapeutic treatment of infectious diseases of the oral cavity.

### Claim 5 (depends on 1, 4)

The bacterial strain of claim 1, for the use of claim 4, wherein the infectious disease of the oral cavity is caused by Gram positive and/or Gram negative bacteria.

### Claim 6 (depends on 1, 4, 5)

The bacterial strain of claim 1, for the use of any one of claims 4-5, wherein the infectious disease of the oral cavity is caries and/or periodontal disease.

### Claim 7 (depends on 1)

The bacterial strain of claim 1, for use as a probiotic, medical food composition or functional food to improve oral health.

### Claim 8 (depends on 1)

A probiotic or medical food composition or a functional food that comprises the bacterial strain as defined in claim 1.

### Claim 9 (depends on 1)

A pharmaceutical composition that comprises the bacterial strain as defined in claim 1.

### Claim 10 (depends on 1)

An oral health composition that comprises the bacterial strain as defined in claim 1.

### Claim 11 (depends on 8, 9, 10)

The compositions or functional food as defined in claim 8, pharmaceutical composition as defined in claim 9, or the oral health composition as defined in claim 10, for use in the prevention and/or therapeutic treatment of infectious diseases of the oral cavity.

### Claim 12 (depends on 8, 9, 10, 11)

The compositions or functional food as defined in claim 8, pharmaceutical composition as defined in claim 9 and/or the oral health composition as defined in claim 10, for use according to claim 11, wherein the infectious disease of the oral cavity is caries and/or periodontal disease.

### Claim 13 (depends on 1)

Method for preparing a supernatant comprising:
a) Culturing the bacterial strain of the claim 1, or a bacterial strain which genome has at least 95% average nucleotide identify with the DNA sequence of the whole genome of the bacterial strain of claim 1,
b) Centrifugating the culture of the step a), and
c) Recovering the supernatant obtained from the step b).

### Claim 14 (depends on 13)

A supernatant for use in the prevention or treatment of infectious diseases of the oral cavity, wherein the treatment comprises the preparation of the supernatant according to the claim 13.

### Claim 15 (depends on 14)

The supernatant for use, according to claim 14, wherein the infectious diseases of the oral cavity is caries and/or periodontal disease.
